Clinical trial results

Explore the landscape of Clinical trial results in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial results to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

AnnJi Advances AJ201 into Pivotal Phase 3 ROMA‑KD Trial – The Only Investigational Therapy for SBMA in Late‑Stage Development Worldwide
CompanyDrug

AnnJi Advances AJ201 into Pivotal Phase 3 ROMA‑KD Trial – The Only Investigational Therapy for SBMA in Late‑Stage Development Worldwide

AnnJi Pharmaceutical Co., Ltd. (TPEx: 7754), a clinical‑stage drug development company focused on innovative small molecules, announced that it is proceeding with the U.S. portion of its pivotal Phase 3…

Asymchem's Tianjin Macromolecule Site Passes First FDA Pre‑Approval Inspection – EIR Issued for Commercial API Facility

Asymchem’s Tianjin Macromolecule Site Passes First FDA Pre‑Approval Inspection – EIR Issued for Commercial API Facility

Pfizer's Oral Ritlecitinib Meets Primary Endpoints in Phase III Nonsegmental Vitiligo Trials – Largest‑Ever Oral Systemic Program Clears Path for Global Filings

Pfizer’s Oral Ritlecitinib Meets Primary Endpoints in Phase III Nonsegmental Vitiligo Trials – Largest‑Ever Oral Systemic Program Clears Path for Global Filings

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Legend Biotech’s Carvykti Shows Significant Overall Survival Improvement in Phase III CARTITUDE-4 Study

CompanyDrug

Tracon Pharmaceuticals Halts Development of Envafolimab After Clinical Trial Failure

CompanyDrug

Innovent Biologics Presents Positive Phase I Results for IBI343 at ESMO GI Congress 2024

CompanyMedical Device

Ningbo-Based Jenscare Scientific Announces Successful Follow-up Data for Transjugular Tricuspid Valve Device

CompanyDrug

Henlius Pharmaceutical’s HLX15 Biosimilar Meets Phase I Clinical Endpoints

CompanyDrug

Johnson & Johnson Achieves Positive Phase III Results for Nipocalimab in Generalized Myasthenia Gravis

CompanyDrug

Abbisko Therapeutics Presents Positive Phase II Results for HCC Treatment at ESMO-GI

CompanyDrug

Novo Nordisk’s Ocedurenone Misses Primary Endpoint in Chronic Kidney Disease Trial

Show More